tiprankstipranks
Holding VIRS?
Track your performance easily

VIRS ETF Forecast & Price Targets

See the Price Targets and Ratings of:

VIRS Analyst Ratings

Hold
55ConsensusRatings
36 Buy
18 Hold
1 Sell
Based on the consensus analyst ratings on 55 stocks held in VIRS.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VIRS 12 Month Forecast

Average Price Target

$43.18
Based on 55 Wall Street analysts offering 12 month price targets to VIRS holdings in the last 3 months. The average price target is $43.18 with a high forecast of $51.74 and a low forecast of $35.56. The average price target represents a 7.87% change from the last price of $40.03.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"27":"$27","52":"$52","33.25":"$33.3","39.5":"$39.5","45.75":"$45.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":51.736,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$51.74</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":43.175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$43.17</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":35.561,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$35.56</span>\n  </div></div>","useHTML":true}}],"tickPositions":[27,33.25,39.5,45.75,52],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2024","6":"Apr<br/>2024","9":"Jul<br/>2024","12":"Oct<br/>2024","25":"Oct<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40,40.90276923076923,41.80553846153846,42.70830769230769,43.61107692307692,44.51384615384615,45.41661538461538,46.319384615384614,47.222153846153844,48.124923076923075,49.027692307692305,49.930461538461536,50.83323076923077,{"y":51.736,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40,40.24423076923077,40.488461538461536,40.732692307692304,40.97692307692308,41.22115384615385,41.465384615384615,41.70961538461538,41.95384615384615,42.19807692307692,42.44230769230769,42.68653846153846,42.93076923076923,{"y":43.175,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,40,39.65853846153846,39.317076923076925,38.97561538461539,38.63415384615384,38.292692307692306,37.95123076923077,37.60976923076923,37.268307692307694,36.92684615384616,36.58538461538461,36.243923076923075,35.90246153846154,{"y":35.561,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":29.41,"date":1696204800000,"info":"<div>Price: <b>$29<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":28.38,"date":1698796800000,"info":"<div>Price: <b>$28<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":30.4,"date":1701388800000,"info":"<div>Price: <b>$30<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":32.27,"date":1704153600000,"info":"<div>Price: <b>$32<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":33.34,"date":1706745600000,"info":"<div>Price: <b>$33<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.28,"date":1709251200000,"info":"<div>Price: <b>$35<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.81,"date":1711929600000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":34.17,"date":1714521600000,"info":"<div>Price: <b>$34<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":35.83,"date":1717372800000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":36.14,"date":1719792000000,"info":"<div>Price: <b>$36<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":37.62,"date":1722470400000,"info":"<div>Price: <b>$38<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":38.67,"date":1725321600000,"info":"<div>Price: <b>$39<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40,"date":1727740800000,"info":"<div>Price: <b>$40<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$51.74Average Price Target$43.18Lowest Price Target$35.56
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

VIRS Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Vir Biotechnology, Inc.
5 Buy
3 Hold
0 Sell
Moderate Buy
$32.71
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Moderna
7 Buy
10 Hold
2 Sell
Moderate Buy
$104.53
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Emergent Biosolutions
2 Buy
0 Hold
0 Sell
Moderate Buy
$12.00
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Merck & Company
17 Buy
2 Hold
0 Sell
Strong Buy
$139.53
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Fortrea Holdings Inc.
2 Buy
6 Hold
1 Sell
Hold
$23.71

VIRS Stocks With Highest Downside Potential

No stocks with downside potential were found for this ETF
Please check back later or explore other ETFs for potential investment opportunities.

VIRS ETF FAQ

What is VIRS’s average 12-month price target, according to analysts?
Based on analyst ratings, VIRS’s 12-month average price target is $43.18.
    What is VIRS’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for VIRS, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is VIRS a Buy, Sell or Hold?
        Currently, no data Available
        What is VIRS’s price target?
        The average price target for VIRS is $43.18. This is based on 55 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
        The highest analyst price target is $51.74 ,the lowest forecast is $35.56. The average price target represents N/A Increase from the current price of N/A.
          What do analysts say about VIRS?
          Not enough analysts have published a price target to provide an average price target.
          How can I buy shares of VIRS?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis